Annual Current Liabilities
$7.55 M
+$2.94 M+63.88%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual total current liabilities is $7.55 million, with the most recent change of +$2.94 million (+63.88%) on December 31, 2023.
- During the last 3 years, FENC annual current liabilities has risen by +$5.21 million (+221.82%).
- FENC annual current liabilities is now -30.81% below its all-time high of $10.92 million, reached on December 31, 2010.
Performance
FENC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$7.43 M
-$314.00 K-4.05%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly total current liabilities is $7.43 million, with the most recent change of -$314.00 thousand (-4.05%) on September 30, 2024.
- Over the past year, FENC quarterly current liabilities has dropped by -$314.00 thousand (-4.05%).
- FENC quarterly current liabilities is now -32.43% below its all-time high of $11.00 million, reached on March 31, 2013.
Performance
FENC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
FENC Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +63.9% | -4.0% |
3 y3 years | +221.8% | +85.0% |
5 y5 years | +361.4% | +85.0% |
FENC Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +356.6% | -24.4% | +349.5% |
5 y | 5-year | at high | +356.6% | -24.4% | +776.8% |
alltime | all time | -30.8% | +1778.9% | -32.4% | +2329.7% |
Fennec Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.43 M(-4.1%) |
Jun 2024 | - | $7.75 M(-21.2%) |
Mar 2024 | - | $9.84 M(+30.2%) |
Dec 2023 | $7.55 M(+63.9%) | $7.55 M(+93.0%) |
Sep 2023 | - | $3.91 M(+3.6%) |
Jun 2023 | - | $3.78 M(-6.0%) |
Mar 2023 | - | $4.02 M(-12.8%) |
Dec 2022 | $4.61 M(+178.7%) | $4.61 M(+57.5%) |
Sep 2022 | - | $2.93 M(-3.6%) |
Jun 2022 | - | $3.04 M(+42.2%) |
Mar 2022 | - | $2.14 M(+29.1%) |
Dec 2021 | $1.65 M(-29.5%) | $1.65 M(-17.9%) |
Sep 2021 | - | $2.01 M(+137.5%) |
Jun 2021 | - | $848.00 K(-70.7%) |
Mar 2021 | - | $2.89 M(+23.2%) |
Dec 2020 | $2.35 M(+3.3%) | $2.35 M(-18.6%) |
Sep 2020 | - | $2.88 M(-9.6%) |
Jun 2020 | - | $3.19 M(+67.3%) |
Mar 2020 | - | $1.91 M(-16.0%) |
Dec 2019 | $2.27 M(+38.7%) | $2.27 M(+150.9%) |
Sep 2019 | - | $905.00 K(-33.1%) |
Jun 2019 | - | $1.35 M(-6.8%) |
Mar 2019 | - | $1.45 M(-11.4%) |
Dec 2018 | $1.64 M(-0.4%) | $1.64 M(-21.1%) |
Sep 2018 | - | $2.08 M(+145.1%) |
Jun 2018 | - | $847.00 K(-27.8%) |
Mar 2018 | - | $1.17 M(-28.6%) |
Dec 2017 | $1.64 M(+309.0%) | $1.64 M(+59.6%) |
Sep 2017 | - | $1.03 M(+77.6%) |
Jun 2017 | - | $580.00 K(+35.8%) |
Mar 2017 | - | $427.00 K(+6.2%) |
Dec 2016 | $402.00 K(-14.6%) | $402.00 K(+11.7%) |
Sep 2016 | - | $360.00 K(-20.2%) |
Jun 2016 | - | $451.00 K(+30.7%) |
Mar 2016 | - | $345.00 K(-26.8%) |
Dec 2015 | $471.00 K(-73.2%) | $471.00 K(+9.3%) |
Sep 2015 | - | $431.00 K(-43.2%) |
Jun 2015 | - | $759.00 K(-32.4%) |
Mar 2015 | - | $1.12 M(-36.2%) |
Dec 2014 | $1.76 M(-45.2%) | $1.76 M(-54.9%) |
Sep 2014 | - | $3.90 M(-31.6%) |
Jun 2014 | - | $5.71 M(-0.4%) |
Mar 2014 | - | $5.73 M(+78.6%) |
Dec 2013 | $3.21 M(-56.2%) | $3.21 M(-32.7%) |
Sep 2013 | - | $4.77 M(+37.8%) |
Jun 2013 | - | $3.46 M(-68.6%) |
Mar 2013 | - | $11.00 M(+50.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | $7.32 M(+33.8%) | $7.32 M(+344.8%) |
Sep 2012 | - | $1.65 M(+5.9%) |
Jun 2012 | - | $1.55 M(-28.1%) |
Mar 2012 | - | $2.16 M(-60.5%) |
Dec 2011 | $5.47 M(-49.9%) | $5.47 M(-45.0%) |
Sep 2011 | - | $9.94 M(+32.3%) |
Jun 2011 | - | $7.51 M(-5.2%) |
Mar 2011 | - | $7.92 M(-27.4%) |
Dec 2010 | $10.92 M(+2499.3%) | $10.92 M(+3467.6%) |
Sep 2010 | - | $306.00 K(-17.3%) |
Jun 2010 | - | $370.00 K(-12.5%) |
Mar 2010 | - | $423.00 K(+0.7%) |
Dec 2009 | $420.00 K(-82.7%) | $420.00 K(+24.6%) |
Sep 2009 | - | $337.00 K(-54.8%) |
Jun 2009 | - | $745.00 K(-53.2%) |
Mar 2009 | - | $1.59 M(-34.4%) |
Dec 2008 | $2.43 M(+1.2%) | $2.43 M(-16.3%) |
Sep 2008 | - | $2.90 M(+20.8%) |
Jun 2008 | - | $2.40 M(+0.6%) |
Mar 2008 | - | $2.39 M(-0.5%) |
Dec 2007 | $2.40 M(-48.8%) | $2.40 M(+13.9%) |
Sep 2007 | - | $2.11 M(+42.2%) |
Jun 2007 | - | $1.48 M(-27.7%) |
Mar 2007 | - | $2.05 M(-56.3%) |
Dec 2006 | $4.70 M(+76.2%) | $4.70 M(+37.8%) |
Sep 2006 | - | $3.41 M(+44.7%) |
Jun 2006 | - | $2.35 M(-2.6%) |
Mar 2006 | - | $2.42 M(-9.3%) |
Dec 2005 | $2.66 M(+80.6%) | $2.66 M(+27.2%) |
Sep 2005 | - | $2.09 M(-22.5%) |
Jun 2005 | - | $2.70 M(+70.8%) |
Mar 2005 | - | $1.58 M(+14.9%) |
Sep 2004 | - | $1.38 M(-6.7%) |
Jun 2004 | $1.47 M(+35.6%) | $1.47 M(+52.7%) |
Mar 2004 | - | $966.00 K(-20.6%) |
Dec 2003 | - | $1.22 M(+41.9%) |
Sep 2003 | - | $857.30 K(-21.2%) |
Jun 2003 | $1.09 M(+56.5%) | $1.09 M(+57.4%) |
Mar 2003 | - | $690.90 K(-22.3%) |
Dec 2002 | - | $888.80 K(-7.4%) |
Sep 2002 | - | $960.20 K(+38.2%) |
Jun 2002 | $694.90 K(+32.3%) | $694.90 K(+34.1%) |
Mar 2002 | - | $518.30 K(+12.9%) |
Dec 2001 | - | $458.90 K(+0.1%) |
Sep 2001 | - | $458.30 K(-12.8%) |
Jun 2001 | $525.30 K(+9.6%) | $525.30 K(+18.3%) |
Dec 2000 | - | $444.00 K |
Jun 2000 | $479.50 K | - |
FAQ
- What is Fennec Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual current liabilities year-on-year change?
- What is Fennec Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly current liabilities year-on-year change?
What is Fennec Pharmaceuticals annual total current liabilities?
The current annual current liabilities of FENC is $7.55 M
What is the all time high annual current liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total current liabilities is $10.92 M
What is Fennec Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, FENC annual total current liabilities has changed by +$2.94 M (+63.88%)
What is Fennec Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of FENC is $7.43 M
What is the all time high quarterly current liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total current liabilities is $11.00 M
What is Fennec Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, FENC quarterly total current liabilities has changed by -$314.00 K (-4.05%)